Figures & data
Figure 1 Fingolimod first-dose observation experience and treatment satisfaction survey flow diagram.
Abbreviations: TSQM, Treatment Satisfaction Questionnaire for Medication; DMT, disease-modifying therapy; MS, multiple sclerosis; n, number.
![Figure 1 Fingolimod first-dose observation experience and treatment satisfaction survey flow diagram.](/cms/asset/bfdd11f3-87b5-4cb6-b77d-6df262ee6da8/dppa_a_41992_f0001_b.jpg)
Figure 2 Study accrual and attrition.
Abbreviations: N, number; MS, multiple sclerosis.
![Figure 2 Study accrual and attrition.](/cms/asset/b58e1dd0-bd37-439a-b06e-7278e27d23ed/dppa_a_41992_f0002_b.jpg)
Table 1 Sociodemographic and clinical characteristics
Table 2 Reasons for starting or switching to fingolimod
Figure 3 First dose experience.
![Figure 3 First dose experience.](/cms/asset/f1b1f145-3855-4c2e-866c-c7c9f3b377a6/dppa_a_41992_f0003_c.jpg)
Figure 4 TSQM scale scores, overall and by treatment experience.
![Figure 4 TSQM scale scores, overall and by treatment experience.](/cms/asset/3b8f5be5-3e87-4b4b-8421-097db4ce4bd3/dppa_a_41992_f0004_c.jpg)
Table S1 Survey questions about first-dose experience